Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and hCG Response in PCOS
NCT03489668Unknown
- Sponsor
- Poznan University of Medical Sciences
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: 17-hydroxyprogesterone response to hCG at 24 hours. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03489668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03489668.